Assignee
GUANGZHOU KANGRUI BIOLOGICAL PHARMACEUTICAL TECH CO LTD
CN·3 granted patents·1 pending application·0 citations·filing 2014–2021
Top patents by PatentIndex Score
4 records- 0155US9540381B2Anti-angiogenesis compound, intermediate and use thereofGUANGZHOU KANGRUI BIOLOGICAL PHARMACEUTICAL TECH CO LTD·Filed 2014·Granted Jan 10, 2017·0 cites·12 claims
- 0253US2023301904A1Formulation for Treating Ophthalmic ConditionsGUANGZHOU KANGRUI BIOLOGICAL PHARMACEUTICAL TECH CO LTD·Filed 2021·Application pending·0 cites
- 0348US10064864B2Anti-angiogenesis compound, intermediate and use thereofGUANGZHOU KANGRUI BIOLOGICAL PHARMACEUTICAL TECH CO LTD·Filed 2016·Granted Sep 4, 2018·0 cites·8 claims
- 0437US10093694B2Compounds for treating eye disorders or diseasesGUANGZHOU KANGRUI BIOLOGICAL PHARMACEUTICAL TECH CO LTD·Filed 2017·Granted Oct 9, 2018·0 cites·18 claims
Join the waitlist — get patent alerts
Get an alert when GUANGZHOU KANGRUI BIOLOGICAL PHARMACEUTICAL TECH CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →